SciELO - Scientific Electronic Library Online

 
vol.20 número2Factores de riesgo para infertilidad en mujeres en un Hospital PeruanoActitudes y creencias anticonceptivas entre los adultos jóvenes índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

  • Não possue artigos citadosCitado por SciELO

Links relacionados

  • Não possue artigos similaresSimilares em SciELO

Compartilhar


Revista de la Facultad de Medicina Humana

versão impressa ISSN 1814-5469versão On-line ISSN 2308-0531

Rev. Fac. Med. Hum. vol.20 no.2 Lima abr./jun 2020

http://dx.doi.org/10.25176/rfmh.v20i2.2711 

Original article

Predictor factors for multidrug-resistant tuberculosis among patients with pulmonary tuberculosis in Huánuco, Peru. 2010-2015

Anghella Valdivia-Gómez1 

Noelia Zavala-Lazo1 

Bernardo Dámaso-Mata1  2 

Vicky Panduro-Correa1  3 

Edinho Segama-Fabian4 

Kovy Arteaga-Livias1  2 

1Facultad de Medicina. Universidad Nacional Hermilio Valdizán, Huánuco-Perú.

2Hospital II EsSalud, Huánuco-Perú.

3Hospital Regional Hermilio Valdizán, Huánuco-Perú.

4Hospital Nacional Ramiro Prialé, Huancayo-Perú.

ABSTRACT

Introduction:

In the city of Huánuco and around the world, there is a progressive increase in cases of Tuberculosis and multidrug-resistant Tuberculosis, for this reason it was necessary to identify predictors to develop multidrug-resistant Tuberculosis.

Objective:

To determine if persistent fever, cavitary radiographic pattern and positive smear microscopy at the first month of treatment, are predictors of multidrug-resistant Tuberculosis in patients with Pulmonary Tuberculosis, in four health facilities in the city of Huánuco, between January 2010 and December 2015.

Methods:

Case and control study. We considered 37 cases and 111 controls. Data were collected from medical records.

Results:

The predictive factors found in the bivariate analysis were persistence of fever at 2 weeks (p = 0.001, OR 0.05, CI 0.01-0.5), cavitary radiographic pattern (p = 0.000, OR 11.6, 95%IC 4.6-26.5), and smear microscopy positivity at the first month of treatment (p = 0.00, OR 13.5, 95%CI 4.1-44.6). These were confirmed by multivariate analysis (p = 0.012, p = 0.00, p = 0.00 respectively).

Conclusion:

The persistence of fever at two weeks, cavitary radiographic pattern and positive smear microscopy at the first month of treatment were predictive factors associated independently for the diagnosis of multidrug-resistant Tuberculosis.

Keywords: Drug-Resistant Tuberculosis; Case Studies; and Controls (source: MeSH NLM).

INTRODUCTION

Multidrug-resistant tuberculosis (MDR-TB) is defined as simultaneous resistance to isoniazid and rifampicin, and is now considered a major public health problem, mainly in developing countries where there are high rates of poverty1.

According to WHO, in 2016 approximately 490 000 people worldwide developed MDR-TB, of which almost 50% were in India, the People's Republic of China and the Russian Federation1. In the countries of the Americas, the overall rate of new cases in 2011 was 28 per 100,000 inhabitants, with Haiti and Bolivia being the countries with the highest incidence; however, the cases reported by Brazil and Peru accounted for more than half of all cases in the region2. In Peru, according to data published by the Ministry of Health and the WHO, 5% of all TB cases in Peru are MDR-TB and 82% of these are concentrated in the areas of Lima and Callao3,4. In Huanuco, 22 new cases confirmed MDR-TB were registered during 2014, of which 59% corresponded to the province of Huánuco, being Huánuco, the city where most of the MDR-TB cases are concentrated5.

Sensitivity tests, both molecular and culture, are essential markers for the proper diagnosis and management of MDR-TB; Unfortunately, some of these tests are expensive, others have late results and are not available, especially in areas with limited resources such as Huánuco, which is located in the central-eastern part of Peru, is the second poorest region in Peru with 30% of people in extreme poverty, a quarter of its population does not have sewage service, 9.2% of the inhabitants do not have access to drinking water, and where a significant burden of tuberculosis cases is currently concentrated; Therefore, it is imperative to develop new, faster and more affordable methodologies to facilitate the identification of patients with MDR-TB6.

In this context, a series of studies have been carried out worldwide using clinical, radiology, laboratory tests and even immunogenetics, to establish predictive factors for MDR-TB, among whose results the association with HIV infection, the presence of hilar or mediastinal adenopathies in chest radiography and the absence of infiltrates in chest radiography stand out7; Similarly, other associated factors are being young, abandoning treatment and the presence of cavitary lesions in the chest X-ray8; while in Peru another study found that contact with a patient with MDR-TB within the family, an abnormal lung exam and the cavitary pattern in the chest X-ray are factors related to presenting MDR-TB6.

Under these considerations, we can observe how important it is to identify predictive factors in MDR-TB that can be accessible in our reality, being this necessary to carry out an active and reasoned search of patients with potential risk, decrease the time of diagnosis and offer an adequate and timely treatment; achieving in this way better control of tuberculosis, avoiding the transmission of the disease and consequently providing adequate secondary prevention. All these actions will have a greater impact on the population with fewer economic resources, who are the most vulnerable to this disease in Huánuco, Peru and other parts of the world9,10.

In such a scenario, the objectives of our study were to establish predictors for developing MDR-TB from clinical, radiological and laboratory parameters that are easily accessible in limited-resource areas.

METHODS

Design

An observational, analytical, longitudinal, retrospective, case-control study was conducted between January 2010 and December 2015; it included records of patients with pulmonary tuberculosis from four health facilities in the city of Huánuco: Aparicio Pomares Health Center (CS), Las Moras CS, EsSalud Huánuco Hospital II, and Hermilio Valdizán Regional Hospital.

Population and sample

During the study period, 200 clinical records of patients with pulmonary tuberculosis were found, of which 37 patients were MDR-TB and 111 were sensitive TB, of which 52 records were excluded from the study because of incomplete data needed for the research.

Procedures and variables

Clinical, radiographic and bacilloscopy evaluations were carried out at the beginning of treatment and then monthly until treatment was completed in the Tuberculosis Control Program (TCP) services from each of the establishments included in the study, which had a pulmonologist or infectologist, a licensed nurse, and technical staff; and where patients with pulmonary tuberculosis, both sensitive and MDR, received specific treatment under direct observation.

All patients who had rapid and/or conventional tests resulting in resistance were defined as MDR tuberculosis (case), and all patients diagnosed by rapid tests or conventional tests as sensitive TB (controls), or those who were receiving anti-tuberculosis treatment for sensitive TB and had adequate clinical progress.

Non-probabilistic type sampling was performed on all patients diagnosed with tuberculosis.

The data were obtained by reviewing clinical records, using a collection sheet, which was validated by expert judgement.

Statistical analysis

Data processing was carried out using the software SPSS v. 15.0, using Fisher’s test for the variables diabetes mellitus, drug use and persistent fever after two weeks of treatment; Mann Whitney’s U-test for the age variable and for qualitative variables was used the chi-square statistical test.

Multivariate analysis was performed with the variables that obtained statistical significance in bivariate analysis. A predictive model was constructed using multivariate logistic regression with goodness-of-fit test to evaluate predictivity. The generated table presents only the variables that maintain the statistical significance, besides considering age and sex as confusing variables and controlling bias.

Ethical considerations

The data were confidential and the identity of the patients was protected by unique code assignment and the ethical principles of the Helsinski Declaration of the World Medical Association were respected. The research protocol, prior to its execution, was reviewed and approved by the research ethics committee of the Faculty of Medicine of the Universidad Nacional Hermilio Valdizán de Huánuco.

RESULTS

During the years 2010 to 2015 in the four health facilities that were included in the study, a total of 200 cases of Pulmonary Tuberculosis were registered, 90% of which were complete and with adequate follow-up. Thirty-seven cases were included that were diagnosed as MDR-TB, to which 111 controls were assigned, whose epidemiological characteristics are shown inTable 1.

The bivariate analysis found that the association between MDR-TB and alcohol use was statistically significant, but not with drug or tobacco use. The presence of contacts with tuberculosis in patients with pulmonary tuberculosis was only 1% in controls and 0% in the cases of MDR-TB patients, and no association was found. A significant association was found with the regularity of treatment of patients with sensitive TB, as a protective factor for the development of MDR-TB.

The most frequent radiographic patterns in the diagnosis of patients with MDR-TB were the cavity pattern and the reticular one, showing a statistically significant association with the cavity radiographic pattern. The relationship between MDR-TB and positive bacilloscopy at diagnosis and the first month of treatment was statistically significant, the rest of the analysis can be seen intable 2.

In the multivariate analysis shown intable 3the association of MDR-TB with persistent fever, the cavity radiographic pattern, positive bacilloscopy at the first month of treatment, productive cough at diagnosis and lung crackles at diagnosis were statistically significant.

Table 1.  Epidemiological characteristics of patients with pulmonary tuberculosis in Huánuco from 2010 to 2015 (n = 148) 

Characteristics Frecuency Porcentage
Hospital / Healthcare Facility
Health Center Aparicio Pomares Health Center Aparicio Pomares Regional Hermilio Valdizán Medrano Hospital EsSalud Hospital II 61 50 22 15 41,2% 33,8% 14,9% 10,1%
Year of Medical History
2010 2011 2012 2013 2014 2015 12 25 24 30 36 21 8,1% 16,9% 16,2% 20,3% 24,3% 14,2%
Genre
Female Male 62 86 41,9% 58,1%
Level of education
No education Primay Seconday Superior 8 29 82 29 5,4% 19,6% 55,4% 19,6%
Marital Status
Married Single Widower 32 111 5 21,6% 75,0% 3,4%
Ocupation
Estudient No Health Professional Health Professional Without ocupation 48 88 2 10 32,4% 59,5% 1,4% 6,8%
Place of origin (District/ Province)
Amarilis (Huánuco) Ambo (Ambo) Chinchao (Huánuco) Huánuco (Huánuco) Panao (Pachitea) Pillcomarca (Huánuco) Rondos (Lauricocha) 26 2 1 116 1 1 1 17,6% 1,4% 0,7% 78,4% 0,7% 0,7% 0,7%
Age (años) (X + DS) 30,85 + 16,20

Table 2.  Bivariate analysis of MDR-TB in patients with pulmonary tuberculosis in Huánuco from 2010 to 2015 (n = 148) 

Characteristics Tuberculosis X2 p OR CI 95%
MDR n=37 % Sensible n=111 % Inf Sup
Marital status
No single Single 14 23 40,5 59,5 22 89 19,8 80,2 4,89 0,027 2,46 1,09 5,55
Alcohol Consumption
Yes No 16 21 43,2 56,8 19 92 17,1 82,9 10,49 0,003 3,69 1,63 8,35
Diabetes Mellitus
Yes No 4 33 10,8 89,2 1 110 0,9 99,1 5,59 0,014 * 13,33 1,44 123,45
Regularity of treatmento
Yes No 27 10 73,0 37,0 101 10 91,0 9,0 6,244 0,0125 0,27 0,10 0,71
Productive caough st diagnosis
Yes No 31 6 83,8 16,2 48 63 43,2 56,8 16,73 0,000 6,78 2,62 17,56
Crackles at diagnosis
Yes No 11 26 29,7 70,3 9 102 8,1 91,9 9,32 0,002 4,79 1,79 12,78
Fever after 2 weeks of treatment
Yes No 5 32 9,0 91,0 1 110 1,4 98,6 8,34 0,004* 17,19 1,94 152,48
X-ray pattern at diagnosis
Cavity pattern No cavity pattern 22 15 59,5 40,5 13 98 11,7 88,3 35,04 0,000 11,06 4,60 26,52
Baciloscoy at first month of treatment
Positive Negative 23 14 52,9 47,1 8 103 7,7 92,3 47,35 0,000 21,15 7,94 56,31
Age (X + DS) 34,05 + 14,45 29,78 + 16,67 1531,00 # 0,021
IMC al diagnóstico (X + DS) 21,74 + 2,37 20,53 + 2,92 1561,50 # 0,029

* Fisher´s exact test / # U de Mann Whitney

Table 3.  Logistic regression of MDR TB with predictive factors in patients with pulmonary tuberculosis in the city of Huánuco from 2010 to 2015 (n = 148) 

Characteristic Z p OR CI 95%
Inferior Superior
Genre -0,04 0,969 0,97 0,3 3,4
Age 0,68 0,741 1,0 1,0 1,1
Cavity radiographic pattern 3,90 0,000 18,02 4,2 77,1
Fever at two weeks 2,50 0,012 61,8 2,4 1570,0
Positive basiloscopy at the first month of treatment 4,85 0,000 47,4 9,9 225,8
Productive cough at diagnosis 2,43 0,015 5,48 1,4 21,6
Crepitus at diagnosis 2,38 0,017 8,4 1,4 48,1

Goodness of fit test: Hosmer-Lemeshow chi2(10) = 3,49 Prob > chi2 = 0,9675

DISCUSSION

Tuberculosis is a huge public health problem worldwide and in Peru, despite a reduction in its incidence in recent years, it still mainly affects the population with fewer economic resources2.

One of the objectives of our study was to find the association between MDR-TB and persistent fever, defined as fever lasting more than 2 weeks after starting treatment with first-line drugs (isoniazid, rifampicin, pyrazinamide, ethambutol); this was statistically significant, which means that the persistence of fever despite starting treatment with anti-tuberculosis drugs predicts the presence of MDR-TB. This is similar to what was found by Solomon et al, who, when evaluating the response of fever to anti-tuberculosis therapy, found that the decrease or disappearance of fever was less likely in patients with MDR-TB than in those with sensitive tuberculosis7.

Chest X-ray is considered a mainstay in the diagnosis of pulmonary tuberculosis since a normal chest X-ray decreases the likelihood of active disease. Pulmonary tuberculosis can manifest itself in different radiological patterns, depending on the age group and the patient's immune status, among other factors. The cavity pattern is produced when liquefied caseosal material is expelled from the center of the lesion into the bronchial tree. It can vary in size and can be single or multiple. In our study, we found a significant association of MDR-TB with the cavity radiographic pattern. In countries with high prevalence and incidence of TB, studies have been conducted to look for the association between MDR-TB and different radiographic patterns. Chuchottaworn et Cols. carried out a study in Thailand to determine the risk factors associated with MDR-TB, finding, as we did, an association with the presence of cavities in the chest x-ray; additionally, they found statistical significance with certain particular characteristics of the cavities such as: the number of cavities from 3 to more, the maximum diameter greater than 30 mm and more than 2 affected lung areas11. Lai et Cols in 2010, found that patients with XDR-TB (Extremely Resistant) had a significantly higher prevalence of cavitary lung lesions on chest radiography than patients with MDR-TB (p < 0.05)12, suggesting that the presence of cavitary pattern is associated with increased resistance.

A simple laboratory predictor, routinely obtained in every patient diagnosed with pulmonary tuberculosis, is baciloscopy. In the case of our study, the clear association between persistently positive baciloscopy at the first month of treatment and the subsequent diagnosis of MDR-TB is evident; it coincides with the results obtained in a Peruvian investigation in which it is concluded that of 1545 patients studied, 145 of them had positive baciloscopy during the first 60 days of treatment, and 21.8% of these patients had some type of resistance13. In contrast, a study by Kumar et al. found positive baciloscopy at two, four, five and six months after the start of treatment, however, when cultures were taken from these patients they were negative by more than 60%, concluding that starting empirical treatment for MDR-TB based on persistently positive baciloscopy is incorrect and would have dangerous consequences14.

Our study found no association between sex and the possibility of developing MDR-TB, similar to research conducted in Peru, where despite the higher frequency of male sex in the control group, when the statistical analysis was performed, no significant differences existed15; however, research conducted in China showed that male sex was more likely to develop MDR-TB than female sex (8.3% vs. 3.3%; X2 = 8.69, p < 0.001)16.

The age groups in which MDR-TB can occur are varied and depend on several factors. In our study, the mean age for cases was 33.12 + 11.66 years, and for controls, 29.82 + 16.69 years, without being statistically significant. These findings are consistent with the results of the Mekonnen study, which assessed the prevalence and risk factors of MDR-TB in Ethiopia, where the mean and median age was 32 and 29 years respectively, but no age group was statistically significant17. Conversely, some research has found a statistically significant association between specific age groups and the risk of developing MDR-TB, however, the results of the studies are not uniform because they differ by age group. For example, Avalos-Rodriguez et Cols studied the factors associated with primary MDR-TB in Callao, Peru, finding that age greater than 40 years was a protective factor against MDR-TB, that is, the greatest risk was found in younger patients18. Zhao's group, on the other hand, developed a meta-analysis in China, finding a statistically significant association with an older group, between 40 and 60 years of age19.

The present study considered three social factors associated with pulmonary tuberculosis: alcohol, tobacco and drug use. The frequency of use of these was low in both MDR-TB and sensitive patients. In multivariate analysis, no statistically significant association was found with tobacco or drug use, but an association with alcohol use was evidentSimilarly, Odone et Cols. conducted a cohort study in Lima, on the role of social determinants in MDR TB, which included tobacco use among its studied variables and, like our study, found no significant association with having been or currently being a smoker20; likewise, Martinez's group conducted a prospective cohort study in 37 health centers located in poor areas of Lima, finding a significant association between MDR TB and alcohol use11. Concerning drug use, other research finds an association of MDR-TB with drug use, but only with some types of drugs. Young in his study of social and clinical predictors of resistant TB in Monterrey, Mexico, found a significant association of resistant TB (which included MDR-TB) with cocaine use, but not with marijuana, methamphetamine or intravenous drug use21.

The comorbidities assessed in our study were HIV infection and diabetes mellitus. Concerning HIV, no seropositive patients were found within the sample, while the frequency of diabetes mellitus in patients with sensitive TB was only 0.9%, and 10.8% in patients with MDR-TB, data that resulted in a statistically significant association in the bivariate analysis, but due to the very small sample size it requires further study in this regard, since a study conducted in 2014, evidence that diabetes mellitus in the multivariate analysis was not significantly associated with any drug resistance22.

Contact with TB patients is considered a risk factor for MDR-TB according to the Peruvian Ministry of Health's guidelines; which is supported by some research as a meta-analysis developed in New York in which 25 studies were found that evaluated a median of 111 family contacts of drug-resistant patients, the combined yield was 7.8% (95% CI, 5.6% -10.0%) for active tuberculosis and 47.2% (95% CI, 30.0% -61.4%) for latent tuberculosis, although there was significant statistical heterogeneity (P<0.0001), This study concludes that household contact research on anti-tuberculosis drug resistance is a high-performance intervention for the detection of tuberculosis and the prevention of MDR-TB23, contrary to the findings of our study, in which no significant association was found, perhaps due to the low number of contacts with sensitive TB patients and the lack of contacts with MDR-TB patients; Such evidence is also seen in a study in Thailand, where similarly to ours, no statistical association is evident24.

Our study identified regularity and adherence to treatment in patients with sensitive TB as a protective factor against MDR-TB. Irregularity of treatment is considered by many researchers as a risk factor for MDR-TB, as demonstrated by a meta-analysis conducted in China, which in assessing poor adherence to treatment, found that it was a risk factor for developing MDR-TB19.

LIMITATIONS

We found that during the development of our study the most important limitation was the source of information used, since a percentage of the clinical histories used were found to be incomplete, and therefore excluded from the research resulting in fewer patients for the study. Also, our design, being retrospective, presents biases typical of this type of research, so its extrapolation may be limited.

CONCLUSIONS

In our study the predictors independently associated with MDR-TB in patients with pulmonary tuberculosis were persistent fever at two weeks after initiation of treatment, productive cough at diagnosis, lung crackles at diagnosis, cavity radiographic pattern and persistently positive baciloscopy test at the first month of treatment.

REFERENCES

1. Organización Mundial de la Salud. Tuberculosis. Nota descriptiva N°104. Octubre 2016. Disponible en: https://www.who.int/es/news-room/fact-sheets/detail/tuberculosisLinks ]

2. Organización Panamericana de la Salud. La tuberculosis en la Región de las Américas: Informe Regional 2012. Epidemiología, control y financiamiento. Washington, DC: OPS, 2014. Disponible en: https://www.paho.org/hq/dmdocuments/2013/TB-Report-Americas-2012-Spanish.pdf [ Links ]

3. Del Castillo H., Mendoza A., Saravia J., Somocurcio J. Epidemia de tuberculosis multidrogoresistente y extensivamente resistente a drogas en el Perú: Situación y propuestas para su control. Rev Peru Med Exp Salud Pública. 2009; 26(3): 380-86. Disponible en: http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1726-46342009000300018sLinks ]

4. World Health Organization (base de datos en Internet). Diagnosis and notification of resistant TB 2014 (acceso 01 de mayo de 2016). Disponible en: https://www.who.int/tb/areas-of-work/drug-resistant-tb/en/Links ]

5. Oficina de informática, telecomunicaciones y estadística - DIRESA-HCO. Consolidado anual programa PCT a nivel de provincias, distritos, y establecimientos de salud. 2014. Disponible en: https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1&cad=rja&uact=8&ved=2ahUKEwjL2oqik6joAhWlF7kGHWhkAygQFjAAegQIBRAB&url=http%3A%2F%2Fwww.diresahuanuco.gob.pe%2FOITE%2FADJUNTOS%2Fpct%2FPCT14.xls&usg=AOvVaw3S0YLnPYTS5zDXqDxf4z0pLinks ]

6. Martínez D, Heudebert G, Seas C, Henostroza G, Rodriguez M, Zamudio C, et al. Clinical Prediction Rule for Stratifying Risk of Pulmonary Multidrug-Resistant Tuberculosis. Plos One. 2010. 5(8): e12082. DOI: https://doi.org/10.1371/journal.pone.0012082. [ Links ]

7. Salomon N, Perlman DC, Friedmann P, Buchstein S, Kreiswirth BN, Mildvan D. Predictors and Outcome of Multidrug - Resistant Tuberculosis. Clin Res Infect Dis. 1995.21:1245-52. DOI: https://doi.org/10.1093/clinids/21.5.1245 [ Links ]

8. Otu A, Umoh V, Habib A, Ansa V. Prevalence and clinical predictors of drug-resistant tuberculosis in three clinical settings in Calabar, Nigeria. Clin Respir J 2014; 8: 234-239. DOI: https://doi.org/10.1111/crj.12065 [ Links ]

9. Crispín V, Roque M, Salazar EM, Ruiz RJ, Ortiz J, Almonacid A, et al. Factores de Riesgo para tuberculosis multidrogoresistente en Establecimientos de Salud Urbano Marginales 2006 - 2008. Cienc Invest. 2012; 15(1): 25-29. Disponible en: https://revistasinvestigacion.unmsm.edu.pe/index.php/farma/article/view/3181Links ]

10. Álvarez GGC, Sandoval TH, Bojalil JLF. Tuberculosis resistente al tratamiento por fármacos antifímicos. Estudio en el Estado de Chiapas, México. Aten Primaria 1999; 24:209-14. Disponible en: https://www.elsevier.es/es-revista-atencion-primaria-27-articulo-tuberculosis-resistente-al-tratamiento-por-13334Links ]

11. Chuchottaworn C, Thanachartwet V, Sangsayunh P, Myint TZ, Sahassananda D, Surabotsophon M, et al. Risk Factors for Multidrug-Resistant Tuberculosis among Patients with Pulmonary Tuberculosis at the Central Chest Institute of Thailand. Plos One.2015; 10(10):e0139986. DOI: https://doi.org/10.1371/journal.pone.0139986 [ Links ]

12. Lai CC, Tan CK, Lin SH, Liao CH, Huang YT, Chou CH, et al. Clinical and genotypic characteristics of extensively drug-resistant and multidrug-resistant tuberculosis. Eur J Clin Microbiol Infect Dis.2010; 29:597-600. DOI: https://doi.org/10.1007/s10096-010-0874-6 [ Links ]

13. Laura J. Martin, Martha H. Roper, Louis Grandjean. Robert H. Gilman, et al. Rationing tests for drug-resistant tuberculosis - who are we prepared to miss? BMC Medicine (2016); 14:30. DOI: https://doi.org/10.1186/s12916-016-0576-8. [ Links ]

14. Kumar M, Claassens V, Banurekha V. Are we justified in treating for multidrug-resistant tuberculosis based on positive follow-up smear results? Cape Town, South Africa. Int J Tuberc Lung Dis 18(4): 449-453. DOI: https://doi.org/10.5588/ijtld.13.0429. [ Links ]

15. Rodríguez Hidalgo, Luís Alejandro. Factores de riesgo para tuberculosis pulmonar multidrogoresistente en la región La Libertad, Perú. Sciendo. 2012; 15(2):45-54. Disponible en: http://revistas.unitru.edu.pe/index.php/SCIENDO/article/view/492Links ]

16. Yang Y, Zhou C, Shi L, Meng H, Yan H. Prevalence and characterization of drug-resistant tuberculosis in a local hospital of Northeast China. Int J Infect Dis. 2014 May;22:83-6. DOI: https://doi.org/10.1016/j.ijid.2013.12.015 [ Links ]

17. Mekonnen F, Tessema B, Moges F, Gelaw A, Eshetie S, Kumera G. Multidrug resistant tuberculosis: prevalence and risk factors in districts of metema and west armachiho, Northwest Ethiopia. BMC Infectious Diseases.2015; 15:461. DOI: https://doi.org/10.1186/s12879-015-1202-7 [ Links ]

18. Avalos A, Imán F, Virú M, Cabrera J, Zárate A, Meza M, et al. Factores asociados a tuberculosis MDR primaria en pacientes de Callao, Perú. An Fac med. 2014; 75(3):233-6. DOI: https://doi.org/10.15381/anales.v75i3.9775 [ Links ]

19. Zhao P, Xj L, Zhang S, Wang K and Liu C. Social Behaviour Risk Factors for Drug Resistant Tuberculosis in Mainland China: a Meta-analysis. China. J Int Med Res. 2012; 40(2):436-45. DOI: https://doi.org/10.1177/147323001204000205 [ Links ]

20. Odone A, Calderon R, Becerra MC, Zhang Z, Contreras CC, Yataco R, et al. Acquired and Transmitted Multidrug Resistant Tuberculosis: The Role of Social Determinants. Plos One. 2015; 11(1): e0146642. DOI: https://doi.org/10.1371/journal.pone.0146642 [ Links ]

21. Young B, Burgos M, Handal A, Baker J, Rendón A, et al. Social and clinical predictors of drug-resistant tuberculosis in a public hospital, Monterrey, Mexico. Annals of Epidemiology. 2014; 24:771 -75. DOI: https://doi.org/10.1016/j.annepidem.2014.07.001 [ Links ]

22. Nhamoyebonde S, Leslie A. Biological Differences Between the Sexes and Susceptibility to Tuberculosis. Durban, South Africa. J Infect Dis 2014:209 (Suppl 3). S100-S106. DOI: https://doi.org/10.1093/infdis/jiu147 [ Links ]

23. Grandjean L, Crossa A, Gilman R, Herrera C. Tuberculosis in household contacts of multidrug-resistant tuberculosis patients. Int J Tuberc Lung Dis 15(9):1164-1169. DOI: https://doi.org/10.5588/ijtld.11.0030 [ Links ]

24. Shah NS, Yuen CM, Heo M, Tolman AW, Becerra MC. Yield of contact investigations in households of patients with drug-resistant tuberculosis: systematic review and meta-analysis. Clin Infect Dis. 2014: 58(3):381-91. DOI: https://doi.org/10.1093/cid/cit643 [ Links ]

Financing: Self-financed.

Received: January 22, 2020; Accepted: March 10, 2020

Correspondence: Kovy Arteaga-Livias Address: Av. Universitaria N ° 601-607, Pillco Marca 10003, Huánuco. Telephone: (+51) 987 835 517 Email:farteaga@unheval.edu.pe

Authorship contributions: Authors participate in the genesis of the idea, project design, collection and interpretation of data, analysis of results and preparation of the manuscript of the present work of investigation.

Conflict of interest: The authors declare that they have no conflict of interest in the publication of this article.

Creative Commons License Este es un artículo publicado en acceso abierto bajo una licencia Creative Commons